In my post last week, I wrote that there seems to be a limited effect of triggers in the market today. Especially compared to two or three years ago. I will elaborate on this today with Dignitana as case.
The reason Dignitana is a fantastic case is that the company this week received an approval from FDA. Dignitana can now use scalp cooling to ease by-effects of chemotherapy of solid tumour cancers in the US. Until now, their approval from 2015 was limited for treating hair loss caused by chemotherapy with breast cancer. With the new approval, the market opens for both sexes and a range of other types of cancer. The announcement came on Monday evening some hours after the exchange closed. Continue reading
Phase Holographic (PHI) was by far the best performing share of my portfolio in 2015. During 2015, the share moved from 8.5 SEK to 41.40 SEK (+387 %). Then in January 2016, the company announced an issue. The share price immediately fell to a level around 25 SEK, from where is has moved a bit up one week and a bit down the next during entire 2016 and the beginning of 2017. This picture seems have changed lately and the share moves up and seems to have regained the momentum from 2015. The question is why. Continue reading
Since New Year, the Heliospectra share has dropped 19 % and now costs 6.15 SEK. In December, Heliospectra made an oversubscribed issue at 6.5 SEK. After the issue, the company changed CEO. The year-end report showed growth … but perhaps not as much as expected. The growth in the second haft of 2016 was 35 % – and 68 % full year 2016. In other words, growth was high in the first half of 2016, but lost momentum in the second half. Therefore, there is a reason to keep an extra eye on how Heliospectra develops. Continue reading
The thing for the investor about growth shares or start-ups are news to trigger higher share prices. Milestones or accomplishments triggering a steep rise in share price is what we long for. The main activity in 2016, though, from many companies seems to have been raising money through issues. And this does not trigger higher share prices – on the contrary! Press releases announcing news, causing the share to rise have been too sparse so far. This week was different. There was good news from both BrainCool and Recyctec. Continue reading